ARIAD PHARM INC ARIA (NASDAQ)

$ 3.08
19:09
Change: +0.15 (+5.12%)
Volume: 352,500

Avg. Volume: 381135
P/E Ratio: 0
EPS (Annual): -0.89
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 69,450
Institutional Shareholders: 53.58%
Last: 3.08
Change: +0.15 (+5.12%)
Prev. Close: 2.93
Open: 2.93
Day's Range: 2.91 - 3.15
52wk Range: 2.10 - 5.29
Market Value: 203,570
Beta: 1.05
12-month EPS Change: 0.00%
Total Return Last 12 Months: -34.88%
Total Return Last 3 Years: -111.84%
Total Return Last 5 Years: -31.56%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on ARIA
Alert me Subscribe

Earnings roundup: Fortress Investment, PMI

Among the earnings stories for Thursday, Aug. 7, from AP Financial News: NEW YORK (AP)--Asset manager Fortress Investment Group LLC said Thursday its second-quarter loss increased ...READ MORE
Aug 07, 2008 11:41AM
Keywords: FIG, PMI, VG, ARIA

Ariad chief operating officer resigns

(CAMBRIDGE, Mass.)Drug developer Ariad Pharmaceuticals Inc. said Thursday that Senior Vice President and Chief Operating Officer Richard W. Pascoe resigned to take a position elsewhere.READ MORE
Aug 07, 2008 9:52AM
Keywords: ARIA, GENZ

Ariad's 2Q loss widens on higher costs

(CAMBRIDGE, Mass.)Drug developer Ariad Pharmaceuticals Inc. said Thursday its second-quarter loss widened slightly on higher research and development costs. The company lost $17.3 million, or 25 cen...READ MORE
Aug 07, 2008 9:49AM
Keywords: ARIA, MRK

Ariad to receive $2.5 million from partner Merck

(CAMBRIDGE, Mass.)Ariad Pharmaceuticals Inc. said Wednesday it will receive a $2.5 million payment from partner Merck & Co. for moving a cancer drug into midstage clinical trials.READ MORE
Aug 06, 2008 9:09AM
Keywords: ARIA, MRK

Market Spotlight: Cancer drug conference

(NEW YORK)With cancer drugs making up the bulk of sales for many biotech companies, Wall Street is gearing up for one of the year's most anticipated medical conferences, the American Soc...READ MORE
May 28, 2008 5:07PM
Keywords: CELG, DNA, MLNM, IMCL, BMY, MRK, SNY, PARD, ARIA

Sector Wrap: Celgene, Genentech in ASCO spotlight

(NEW YORK)Analysts said Celgene Corp. and Genentech Inc. are their top picks heading into the 44th annual American Society of Clinical Oncology meeting, or ASCO, taking place May 30 to June ...READ MORE
May 16, 2008 4:04PM
Keywords: CELG, DNA, IMCL, AMGN, ARIA, CGRB, EXEL, GENZ, IMGN, OSIP, PARD

Ariad Pharma Creates New COO Position

(CAMBRIDGE, Mass.)Cancer drug developer Ariad Pharmaceuticals Inc. said Wednesday it promoted Richard W. Pascoe from chief commercial officer to the new position of chief operating officer.READ MORE
Feb 13, 2008 7:59AM
Keywords: ARIA
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

PFIZER INC -19.50 18.51
MERCK CO INC -32.20 34.30
JOHNSON AND JOH +18.40 70.67
SCHERING PLOUGH -28.80 19.26
BRISTOL MYERS S -18.00 21.49